| 1.61 0.02 (1.26%) | 09-28 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 | 1-year : | 1.99 |
| Resists | First : | 1.64 | Second : | 1.71 |
| Pivot price | 1.6 |
|||
| Supports | First : | 1.53 | Second : | 1.28 |
| MAs | MA(5) : | 1.62  |
MA(20) : | 1.59 |
| MA(100) : | 1.79 |
MA(250) : | 1.75 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 39.2 |
D(3) : | 50.3 |
| RSI | RSI(14): 49.3 |
|||
| 52-week | High : | 2.97 | Low : | 1.17 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MDAI ] has closed below upper band by 49.0%. Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 64 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.65 - 1.66 | 1.66 - 1.67 |
| Low: | 1.57 - 1.58 | 1.58 - 1.59 |
| Close: | 1.59 - 1.61 | 1.61 - 1.63 |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Fri, 25 Sep 2026
A director acquired shares in Spectral AI (MDAI), bringing his direct holdings to 2,890,847. - Stock Titan
Mon, 21 Sep 2026
Spectral AI (MDAI) director acquires shares and new option awards - Stock Titan
Tue, 11 Aug 2026
Earnings call transcript: Spectral AI posts smaller Q2 2026 loss, shares fall after hours - Investing.com
Mon, 10 Aug 2026
Earnings To Watch: Spectral AI Inc (MDAI) Q2 2026 -- GF Value Sees 60% Downside - Yahoo Finance
Sat, 08 Aug 2026
Spectral AI (MDAI) Climbs 5.4% to $1.75 — Approaching Key Resistance at $1.84 - Put Flow Alert - careplusvn.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 32 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 12.9 (%) |
| Held by Institutions | 19.6 (%) |
| Shares Short | 2,100 (K) |
| Shares Short P.Month | 2,620 (K) |
| EPS | -0.32 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.38 |
| Profit Margin | -65.6 % |
| Operating Margin | -122.7 % |
| Return on Assets (ttm) | -41.9 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -30.4 % |
| Gross Profit (p.s.) | 0.2 |
| Sales Per Share | 0.47 |
| EBITDA (p.s.) | -0.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -5.04 |
| PEG Ratio | 0 |
| Price to Book value | -4.24 |
| Price to Sales | 3.36 |
| Price to Cash Flow | -4.03 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|